DeVita V T
Cancer Res. 1983 Aug;43(8):3969-73.
The National Cancer Program, because of its size, has always been and remains controversial. Some of these controversies have their roots in insupportable myths attending the passage of the Cancer Act in 1971 and the Institute's management of a rapidly changing program, rather than the science it supported. The National Cancer Institute has changed its management systems to improve the governance of science allowing for continual scrutiny, adjustment, and/or phase out of programs that have served their purpose. This is necessary to husband scarce research dollars in support of the plethora of opportunities presented by the powerful new knowledge derived from the current biological revolution.
国家癌症计划因其规模庞大，一直以来都备受争议，且争议仍在持续。其中一些争议源于1971年《癌症法案》通过时那些站不住脚的神话，以及该研究所对快速变化的项目的管理，而非其支持的科学研究。美国国家癌症研究所已改变其管理系统，以改善科学管理，从而能够持续审查、调整和/或淘汰已实现目标的项目。这对于节省稀缺的研究资金，以支持当前生物革命所产生的强大新知识带来的大量机会而言是必要的。
